Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Cancer Research
|
December 14, 2011
Targeting quiescent tumor cells via oxygen and IGF-I supplementation
Alastair H Kyle, Jennifer H E Baker, Andrew I Minchinton
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 4, 2006
Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts
Lynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Cancer Research
|
September 18, 2004
Microregional effects of gemcitabine in HCT-116 xenografts
Lynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Microvascular Research
|
March 21, 2006
Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay
Jennifer H E Baker, Lynsey A Huxham, Alastair H Kyle, et al.
Microvascular Research
|
November 21, 2007
Exploring vascular dysfunction caused by tirapazamine
Lynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Molecular Cancer Therapeutics
|
August 22, 2014
Tissue penetration and activity of camptothecins in solid tumor xenografts
Alastair H Kyle, Jennifer H E Baker, Maria-Jose Gandolfo, et al.
Magnetic Resonance in Medicine
|
October 29, 2018
Fast and sensitive dynamic oxygen-enhanced MRI with a cycling gas challenge and independent component analysis
Firas Moosvi, Jennifer H E Baker, Andrew Yung, et al.
Cancer Research
|
October 3, 2003
Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent
Alastair H Kyle, Lynsey A Huxham, Jennifer H E Baker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 2, 2009
Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging
Lauren J Bains, Jennifer H E Baker, Alastair H Kyle, et al.
Scientific Reports
|
August 1, 2023
DNA-PK inhibition extends the therapeutic effects of Top2 poisoning to non-proliferating cells, increasing activity at a cost
Taixiang Wang, Alastair H Kyle, Jennifer H E Baker, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Cancer Research
|
December 14, 2011
Targeting quiescent tumor cells via oxygen and IGF-I supplementation
Alastair H Kyle, Jennifer H E Baker, Andrew I Minchinton
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 4, 2006
Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts
Lynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Cancer Research
|
September 18, 2004
Microregional effects of gemcitabine in HCT-116 xenografts
Lynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Microvascular Research
|
March 21, 2006
Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay
Jennifer H E Baker, Lynsey A Huxham, Alastair H Kyle, et al.
Microvascular Research
|
November 21, 2007
Exploring vascular dysfunction caused by tirapazamine
Lynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Molecular Cancer Therapeutics
|
August 22, 2014
Tissue penetration and activity of camptothecins in solid tumor xenografts
Alastair H Kyle, Jennifer H E Baker, Maria-Jose Gandolfo, et al.
Magnetic Resonance in Medicine
|
October 29, 2018
Fast and sensitive dynamic oxygen-enhanced MRI with a cycling gas challenge and independent component analysis
Firas Moosvi, Jennifer H E Baker, Andrew Yung, et al.
Cancer Research
|
October 3, 2003
Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent
Alastair H Kyle, Lynsey A Huxham, Jennifer H E Baker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 2, 2009
Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging
Lauren J Bains, Jennifer H E Baker, Alastair H Kyle, et al.
Scientific Reports
|
August 1, 2023
DNA-PK inhibition extends the therapeutic effects of Top2 poisoning to non-proliferating cells, increasing activity at a cost
Taixiang Wang, Alastair H Kyle, Jennifer H E Baker, et al.
Page
of 3